Recainam

Public-database records for Recainam (CAS 74752-07-1), reproduced here for independent cross-checking.

How this substance is indexed

Documented uses

• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Names this substance appears under

Recainam hydrochloride; Recainam HCl; Vanorm; 74752-07-1; WY-42,362 HCL; 18KSR3844V; WY-42362 HCL; DTXSID20225733; RefChem:178711; DTXCID50148224; Recainam hydrochloride [USAN]; UNII-18KSR3844V; WY 42,362 HCl; Recainam (hydrochloride); 1-(3-(Isopropylamino)propyl)-3-(2,6-xylyl)urea monohydrochloride; 1-(2,6-dimethylphenyl)-3-[3-(propan-2-ylamino)propyl]urea;hydrochloride

Computed molecular descriptors

Database abstract

Recainam · CAS 74752-07-1 · C15H26ClN3O. UNII 18KSR3844V.

Source: PubChem / Wikidata; the batch COA governs where values differ.